Nutex Health (NASDAQ:NUTX) Stock Price Down 7.7% – Time to Sell?

Nutex Health Inc. (NASDAQ:NUTX) shares traded down 7.7% during mid-day trading on Thursday. The company traded as low as $175.65 and last traded at $174.6090. 56,657 shares traded hands during mid-day trading, a decline of 66% from the average daily volume of 165,841 shares. The stock had previously closed at $189.19.

Analyst Upgrades and Downgrades

Several analysts recently commented on the stock. B. Riley Financial raised their price objective on shares of Nutex Health from $325.00 to $357.00 and gave the company a “buy” rating in a research note on Monday. Zacks Research lowered shares of Nutex Health from a “strong-buy” rating to a “hold” rating in a research report on Tuesday, October 6th. Wall Street Zen cut shares of Nutex Health from a “buy” rating to a “hold” rating in a report on Saturday, October 31st. Ladenburg Thalmann & Co. Inc. began coverage on shares of Nutex Health in a research report on Monday, October 26th. They set a “buy” rating and a $336.00 price target for the company. Finally, Weiss Ratings raised Nutex Health from a “hold (c+)” rating to a “buy (b-)” rating in a research note on Tuesday, October 6th. Four equities research analysts have rated the stock with a Buy rating and one has given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $342.00.

Nutex Health Price Performance

The company has a market cap of $1.18 billion, a price-to-earnings ratio of 7.33 and a beta of 0.66. The company has a fifty day simple moving average of $203.19 and a two-hundred day simple moving average of $151.91. The company has a quick ratio of 4.96, a current ratio of 4.76 and a debt-to-equity ratio of 0.59.

Nutex Health (NASDAQ:NUTX) last released its quarterly earnings results on Thursday, November 5th. The company reported $5.71 earnings per share (EPS) for the quarter, topping the consensus estimate of $5.54 by $0.17. Nutex Health had a return on equity of 34.43% and a net margin of 20.68%. The business had revenue of $217.61 million during the quarter, compared to the consensus estimate of $214.82 million. On average, equities research analysts anticipate that Nutex Health Inc. will post 27.70 earnings per share for the current fiscal year.

Insiders Place Their Bets

In other Nutex Health news, Director Scott Saunders sold 203 shares of Nutex Health stock in a transaction dated Friday, September 18th. The shares were sold at an average price of $214.25, for a total transaction of $43,492.75. Following the completion of the transaction, the director owned 400 shares in the company, valued at approximately $85,700. The trade was a 33.67% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 44.68% of the company’s stock.

Institutional Trading of Nutex Health

Several institutional investors and hedge funds have recently modified their holdings of the business. Kilter Group LLC acquired a new stake in shares of Nutex Health in the second quarter valued at approximately $27,000. Allworth Financial LP acquired a new position in shares of Nutex Health during the 2nd quarter worth approximately $35,000. GK Wealth Management LLC acquired a new position in shares of Nutex Health during the 3rd quarter worth approximately $73,000. EverSource Wealth Advisors LLC purchased a new stake in Nutex Health in the 1st quarter valued at approximately $83,000. Finally, Voya Investment Management LLC purchased a new stake in Nutex Health in the 3rd quarter valued at approximately $206,000. Hedge funds and other institutional investors own 5.32% of the company’s stock.

Nutex Health Company Profile

Nutex Health is a Houston-based healthcare company with two main divisions: a Hospital Division and a Management Services Organization (MSO). Its Hospital Division develops and operates micro-hospitals that provide emergency care and other hospital and outpatient services. Through its MSO, Nutex provides administrative, technology, analytics and other management support to affiliated physician-led organizations. These services support care coordination and population health management. Founded by physician Thomas Vo, who serves as the company’s chairman and chief executive officer, Nutex operates in the United States.